RARB
RARB (retinoic acid receptor beta, also known as HAP, NR1B2, RRB2 and RAR-beta) is a ligand-activated nuclear receptor that binds retinoic acid and regulates gene expression. It belongs to the nuclear hormone receptor family, NR1 subfamily. Browse Assay Genie's current range of RARB research reagents below, or read on for the biology behind the target.
RARB is a receptor for retinoic acid. Retinoic acid receptors bind as heterodimers to their target response elements in response to their ligands, all-trans or 9-cis retinoic acid, and regulate gene expression in a range of biological processes. RXR/RAR heterodimers recognise retinoic acid response elements (RARE), which are made up of tandem 5'-AGGTCA-3' sites arranged as DR1 to DR5. Whether or not hormone ligand is present, RARB acts mainly as an activator of gene expression because it binds corepressors only weakly. The RXRA/RARB heterodimer can act as a repressor on the DR1 element and as an activator on the DR5 element. Together with RARG, RARB is required for skeletal growth, matrix homeostasis and growth plate function.
The RARB gene encodes a member of the thyroid-steroid hormone receptor superfamily of nuclear transcriptional regulators. The protein localises to the cytoplasm and to subnuclear compartments. It binds retinoic acid, the biologically active form of vitamin A, which mediates cellular signalling in embryonic morphogenesis, cell growth and differentiation. RARB is thought to limit the growth of many cell types by regulating gene expression. Alternate promoter usage and differential splicing give rise to multiple transcript variants. The mouse ortholog is Rarb.
The gene was first identified in a hepatocellular carcinoma, where it flanks a hepatitis B virus integration site, which explains the early alias HAP. HGNC places it in the retinoic acid receptors gene group, and its previous name was retinoic acid receptor, beta. Researchers working on retinoid signalling, development and growth control often study RARB alongside its heterodimer partner RXRA and the related receptor RARG.
RARB mediates retinoic acid signalling by binding RARE sequences as an RXR/RAR heterodimer and regulating target gene expression.
Retinoic acid acting through its receptors mediates cellular signalling in embryonic morphogenesis, cell growth and differentiation.
Together with RARG, RARB is required for skeletal growth, matrix homeostasis and growth plate function.
RARB is thought to limit growth of many cell types, and the gene was first identified in a hepatocellular carcinoma.
RARB is a nuclear receptor for retinoic acid. As an RXR/RAR heterodimer it binds retinoic acid response elements and regulates gene expression. It acts mainly as an activator, and with RARG it is required for skeletal growth and growth plate function.
RARB is also called HAP, NR1B2, RRB2, RARbeta and RAR-beta, and was previously named retinoic acid receptor, beta. NCBI notes that alternate promoter usage and differential splicing produce multiple transcript variants of the gene.
The mouse ortholog is Rarb. The human gene was first identified in a hepatocellular carcinoma, where it flanks a hepatitis B virus integration site. The protein is thought to limit cell growth through gene regulation. Check the datasheet of any product for its validated reactivity.
Other retinoic acid receptors, retinoid X receptors and nuclear hormone receptors studied in retinoid signalling.
Gene and protein annotations from HGNC, NCBI Gene and UniProt P10826; product specifications from Assay Genie datasheets.